Guardant Health, Inc. (GH) - Market Capitalization

This Guardant Health, Inc. (GH) price chart on the GURU.Markets platform, where the market capitalization stands at 20.94, demonstrates the company's position as a liquid biopsy leader. Guardant Health, Inc. (GH) is implementing advanced AI-driven DNA analysis methods for early tumor detection, leveraging its powerful scientific potential. The brand's impeccable authority among medical professionals is bolstered by the creation of a unique digital ecosystem that transforms non-invasive tests into an indispensable standard of modern therapy.

Guardant Health - GH Market Capitalization (period 07/04/2022 - 11/11/2026)

Summary analytical data breakdowns for Guardant Corp (GH)

- current price and projected stock value:

Stock Price Guardant Health|GH - Fair Value Consensus

- market capitalization indicators:

Market Capitalization Guardant Corp|GH - Real Price to Acquire Entire Company

- issuer book value statistics:

Book Value per Share Guardant Health|GH - Book Capitalization|Market Value to Book Value Ratio guardanthealth.com|GH - Total Business Assets

- debt level and financial liquidity data:

- financial results and valuation multiples details:

GH - Net Profit|Expected Profit Guardant Health, Inc.|GH - Price to Earnings Multiple|Forward P/E Multiple Guardant360|GH - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Guardant Corp|GH - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Guardant Health|GH - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months guardanthealth.com|GH - Expected net earnings per share growth this year|Earnings growth forecast for next year Guardant Health, Inc.

Initial company analysis:GH (Guardant Health)

To minimize the risk of overpaying when building a position, it is essential to evaluate the total value of all company shares, which reflects the market's recognition of the business scale. By analyzing the total market capitalization of the issuer, an investor can see how stable demand for liquid biopsy and the integration of tests into treatment protocols translate into capitalization, confirming the fundamental resilience of Guardant Health, Inc. (GH).

Key competitors